CTT Pharmaceutical CEO Ryan Khouri acquires 3,700 common shares valued at $203.50
CTTH•CEO Ryan Khouri bought 3,700 CTT Pharmaceutical shares at $0.055 each, for $203.50, bringing his directly held stake to 9,433,656 shares.
CTTH•CTTH•CTTH•CEO Ryan Khouri bought 3,700 CTT Pharmaceutical shares at $0.055 each, for $203.50, bringing his directly held stake to 9,433,656 shares.
CTT Pharmaceutical Holdings reported that Khouri purchased 3,700 shares in an open-market transaction at $0.055 per share. His directly held stake rose to 9,433,656 shares.
